Australian medical cannabis company Zelira Therapeutics Ltd ZLDAF reported a positive Phase 1b/2a data readout Tuesday for a clinical trial evaluating its investigational cannabinoid therapy ZLT-101 for treating patients with chronic insomnia.
The study achieved the primary endpoint of a statistically significant improvement in Insomnia Severity Index scores in a trial that recruited 24 chronic insomnia patients ages 25-70, the company said.
The enrolled patients were treated with 14 nights of ZTL-101 and, after a washout period of a week, with 14 nights of placebo. The participants were administered either a single dose or double dose of medication delivered sublingually, according to their symptoms.
ZLT-101 was found to be safe and well-tolerated, according to Zelira.
"Having successfully completed its recent merger, Zelira is now poised to rapidly commercialise the world's first clinically validated cannabis medicine for insomnia into global markets in 2020, including the US, based on the positive results of this study," Zelira Chairman Osagie Imasogie said in a statement.
The company said it expects to release a final report from the clinical study, including a comprehensive suite of secondary endpoints, by the end of March.
After remaining halted for trading since Feb. 14, the OTC-listed shares last exchanged hands at 4 cents, down 32.2%.
Related Links:
Harvest Health Opens Little Rock, Arkansas Medical Marijuana Dispensary
The Industry Calculates Its Bearings After USDA, FDA Set Hemp Rules
Photo courtesy of Zelira Therapeutics.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!